Alternatives to Rowan

Physics-based software platform for molecular discovery and design in life and materials sciences.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI-powered drug discovery platform for accelerated molecular design.

Vivodyne is developing advanced AI models for drug discovery and development.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

AI platform for accelerating novel peptide therapeutic discovery and development.

AI platform accelerating the discovery of novel therapeutics.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

AI-powered platform for antibody discovery and development to create new medicines.

AI platform for drug discovery and development, accelerating research and clinical trials.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered platform for designing novel molecular structures for new medicines.

AI-powered research assistant for scientific literature review and data extraction.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.